| 1 | [SID103240245] | Active | IC50 | 1.6 | In vitro ability to inhibit the transport of [3H]choline in to high affinity choline transport system HAChT [AID52130, Type: Literature] | |   View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 103240245 | | CID | 305 | | Outcome | Active | | IC50 | 1.6 [uM] | | BioAssay | In vitro ability to inhibit the transport of [3H]choline in to high affinity choline transport system HAChT | | AID | 52130 | | BioAssay type | Literature | | Target | | | PubMed | 3950917 | | Data Table |  |
|
| 2 | [SID103240245] | Active | Ki | 18 | Binding affinity towards rat nicotinic acetylcholine receptor alpha2-beta2 expressed in HEK293 cells using [3H]EB as radioligand [AID145983, Type: Literature] | Neuronal acetylcholine receptor subunit alpha-2 [gi:2851491] |   View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 103240245 | | CID | 305 | | Outcome | Active | | Ki | 18 [uM] | | BioAssay | Binding affinity towards rat nicotinic acetylcholine receptor alpha2-beta2 expressed in HEK293 cells using [3H]EB as radioligand | | AID | 145983 | | BioAssay type | Literature | | Target | Neuronal acetylcholine receptor subunit alpha-2 [gi:2851491] | | PubMed | 15050613 | | Data Table |  |
|
| 3 | [SID103240245] | Active | Ki | 21 | Binding affinity towards rat alpha2-beta4 nACh receptor expressed in HEK293 cells using [3H]EB as radioligand [AID225720, Type: Literature] | |   View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 103240245 | | CID | 305 | | Outcome | Active | | Ki | 21 [uM] | | BioAssay | Binding affinity towards rat alpha2-beta4 nACh receptor expressed in HEK293 cells using [3H]EB as radioligand | | AID | 225720 | | BioAssay type | Literature | | Target | | | PubMed | 15050613 | | Data Table |  |
|
| 4 | [SID103240245] | Active | Ki | 34 | Binding affinity towards rat Nicotinic acetylcholine receptor alpha4-beta4 expressed in HEK293 cells using [3H]EB as radioligand [AID146772, Type: Literature] | Neuronal acetylcholine receptor subunit beta-4 [gi:113111] |   View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 103240245 | | CID | 305 | | Outcome | Active | | Ki | 34 [uM] | | BioAssay | Binding affinity towards rat Nicotinic acetylcholine receptor alpha4-beta4 expressed in HEK293 cells using [3H]EB as radioligand | | AID | 146772 | | BioAssay type | Literature | | Target | Neuronal acetylcholine receptor subunit beta-4 [gi:113111] | | PubMed | 15050613 | | Data Table |  |
|
| 5 | [SID103240245] | Active | Ki | 37 | Binding affinity towards rat Nicotinic acetylcholine receptor alpha3-beta2 expressed in HEK293 cells using [3H]EB as radioligand [AID146006, Type: Literature] | Neuronal acetylcholine receptor subunit alpha-3 [gi:113061] |   View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 103240245 | | CID | 305 | | Outcome | Active | | Ki | 37 [uM] | | BioAssay | Binding affinity towards rat Nicotinic acetylcholine receptor alpha3-beta2 expressed in HEK293 cells using [3H]EB as radioligand | | AID | 146006 | | BioAssay type | Literature | | Target | Neuronal acetylcholine receptor subunit alpha-3 [gi:113061] | | PubMed | 15050613 | | Data Table |  |
|
| 6 | [SID103240245] | Active | Ki | 37 | Binding affinity towards rat Nicotinic acetylcholine receptor alpha4-beta2 expressed in HEK293 cells using [3H]EB as radioligand [AID146486, Type: Literature] | Neuronal acetylcholine receptor subunit beta-2 [gi:6226548] |   View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 103240245 | | CID | 305 | | Outcome | Active | | Ki | 37 [uM] | | BioAssay | Binding affinity towards rat Nicotinic acetylcholine receptor alpha4-beta2 expressed in HEK293 cells using [3H]EB as radioligand | | AID | 146486 | | BioAssay type | Literature | | Target | Neuronal acetylcholine receptor subunit beta-2 [gi:6226548] | | PubMed | 15050613 | | Data Table |  |
|
| 7 | [SID103240245] | Active | Ki | 41 | Binding affinity to blood-brain barrier choline transporter in rat brain assessed as inhibition of [3H]choline uptake [AID344669, Type: Literature] | |   View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 103240245 | | CID | 305 | | Outcome | Active | | Ki | 41 [uM] | | BioAssay | Binding affinity to blood-brain barrier choline transporter in rat brain assessed as inhibition of [3H]choline uptake | | AID | 344669 | | BioAssay type | Literature | | Target | | | PubMed | 18793853 | | Data Table |  |
|
| 8 | [SID103240245] | Active | Ki | 41 | Binding affinity to blood-brain barrier choline transporter in rat brain assessed as inhibition of [3H]choline uptake [AID483710, Type: Literature] | |   View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 103240245 | | CID | 305 | | Outcome | Active | | Ki | 41 [uM] | | BioAssay | Binding affinity to blood-brain barrier choline transporter in rat brain assessed as inhibition of [3H]choline uptake | | AID | 483710 | | BioAssay type | Literature | | Target | | | PubMed | 20462759 | | Data Table |  |
|
| 9 | [SID103240245] | Active | Ki | 42 | Inhibition of [3H]-choline brain uptake was determined by in situ brain perfusion studies in male rats [AID52133, Type: Literature] | |   View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 103240245 | | CID | 305 | | Outcome | Active | | Ki | 42 [uM] | | BioAssay | Inhibition of [3H]-choline brain uptake was determined by in situ brain perfusion studies in male rats | | AID | 52133 | | BioAssay type | Literature | | Target | | | PubMed | 15149650 | | Data Table |  |
|
| 10 | [SID103240245] | Active | Ki | 42 | Binding affinity towards rat forebrain nicotinic acetylcholine receptor using [3H]EB as radioligand [AID145685, Type: Literature] | |   View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 103240245 | | CID | 305 | | Outcome | Active | | Ki | 42 [uM] | | BioAssay | Binding affinity towards rat forebrain nicotinic acetylcholine receptor using [3H]EB as radioligand | | AID | 145685 | | BioAssay type | Literature | | Target | | | PubMed | 15050613 | | Data Table |  |
|
| 11 | [SID103240245] | Active | Ki | 48 | Binding affinity towards rat Nicotinic acetylcholine receptor alpha3-beta4 expressed in HEK293 cells using [3H]EB as radioligand [AID146162, Type: Literature] | Neuronal acetylcholine receptor subunit alpha-3 [gi:113061] |   View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 103240245 | | CID | 305 | | Outcome | Active | | Ki | 48 [uM] | | BioAssay | Binding affinity towards rat Nicotinic acetylcholine receptor alpha3-beta4 expressed in HEK293 cells using [3H]EB as radioligand | | AID | 146162 | | BioAssay type | Literature | | Target | Neuronal acetylcholine receptor subunit alpha-3 [gi:113061] | | PubMed | 15050613 | | Data Table |  |
|
| 12 | [SID46392765] | Active | | | Experimentally measured binding affinity data derived from PDB [AID1811, Type: Literature] | Chain A, Multimodular Pneumococcal Cell Wall Endolysin From Phage Cp-1 Complexed With Choline [gi:38492607] |   View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 46392765 | | CID | 305 | | Outcome | Active | | BioAssay | Experimentally measured binding affinity data derived from PDB | | AID | 1811 | | BioAssay type | Literature | | Target | Chain A, Multimodular Pneumococcal Cell Wall Endolysin From Phage Cp-1 Complexed With Choline [gi:38492607] | | PubMed | 18093984 | | Data Table |  |
|
| 13 | [SID53812665] | Active | | | Experimentally measured binding affinity data derived from PDB [AID1811, Type: Literature] | Chain A, Crystal Structure Of Mouse Acetylcholinesterase Complexed With Choline [gi:112491230] |   View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 53812665 | | CID | 305 | | Outcome | Active | | BioAssay | Experimentally measured binding affinity data derived from PDB | | AID | 1811 | | BioAssay type | Literature | | Target | Chain A, Crystal Structure Of Mouse Acetylcholinesterase Complexed With Choline [gi:112491230] | | PubMed | 16837465 | | Data Table |  |
|
| 14 | [SID103240245] | Unspecified | Km | 42 | TP_TRANSPORTER: uptake in Oct1-expressing BALB/3T3 cells [AID680371, Type: other] | Solute carrier family 22 member 1 [gi:189046191] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 103240245 | | CID | 305 | | Outcome | Unspecified | | Km | 42 [uM] | | BioAssay | TP_TRANSPORTER: uptake in Oct1-expressing BALB/3T3 cells | | AID | 680371 | | BioAssay type | other | | Target | Solute carrier family 22 member 1 [gi:189046191] | | PubMed | | | Data Table |  |
|
| 15 | [SID103240245] | Unspecified | IC50 | 55 | TP_TRANSPORTER: inhibition of MPP+ uptake (MPP+: 1 uM) in Xenopus laevis oocytes [AID678794, Type: other] | Solute carrier family 22 member 1 [gi:189046191] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 103240245 | | CID | 305 | | Outcome | Unspecified | | IC50 | 55 [uM] | | BioAssay | TP_TRANSPORTER: inhibition of MPP+ uptake (MPP+: 1 uM) in Xenopus laevis oocytes | | AID | 678794 | | BioAssay type | other | | Target | Solute carrier family 22 member 1 [gi:189046191] | | PubMed | | | Data Table |  |
|
| 16 | [SID103240245] | Unspecified | Km | 102 | TP_TRANSPORTER: uptake in Xenopus laevis oocytes [AID681960, Type: other] | Solute carrier family 22 member 2 [gi:313104182] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 103240245 | | CID | 305 | | Outcome | Unspecified | | Km | 102 [uM] | | BioAssay | TP_TRANSPORTER: uptake in Xenopus laevis oocytes | | AID | 681960 | | BioAssay type | other | | Target | Solute carrier family 22 member 2 [gi:313104182] | | PubMed | | | Data Table |  |
|
| 17 | [SID103240245] | Unspecified | IC50 | 159 | TP_TRANSPORTER: inhibition of TEA uptake (TEA: 100 uM) in Xenopus laevis oocytes [AID678970, Type: other] | Solute carrier family 22 member 2 [gi:81872789] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 103240245 | | CID | 305 | | Outcome | Unspecified | | IC50 | 159 [uM] | | BioAssay | TP_TRANSPORTER: inhibition of TEA uptake (TEA: 100 uM) in Xenopus laevis oocytes | | AID | 678970 | | BioAssay type | other | | Target | Solute carrier family 22 member 2 [gi:81872789] | | PubMed | | | Data Table |  |
|
| 18 | [SID103240245] | Unspecified | Km | 190 | TP_TRANSPORTER: uptake (electrogenesis) in Xenopus laevis oocytes [AID679159, Type: other] | Solute carrier family 22 member 2 [gi:313104182] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 103240245 | | CID | 305 | | Outcome | Unspecified | | Km | 190 [uM] | | BioAssay | TP_TRANSPORTER: uptake (electrogenesis) in Xenopus laevis oocytes | | AID | 679159 | | BioAssay type | other | | Target | Solute carrier family 22 member 2 [gi:313104182] | | PubMed | | | Data Table |  |
|
| 19 | [SID103240245] | Unspecified | Km | 210 | TP_TRANSPORTER: uptake in Xenopus laevis oocytes [AID678957, Type: other] | Solute carrier family 22 member 2 [gi:313104182] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 103240245 | | CID | 305 | | Outcome | Unspecified | | Km | 210 [uM] | | BioAssay | TP_TRANSPORTER: uptake in Xenopus laevis oocytes | | AID | 678957 | | BioAssay type | other | | Target | Solute carrier family 22 member 2 [gi:313104182] | | PubMed | | | Data Table |  |
|
| 20 | [SID103240245] | Unspecified | IC50 | 217 | TP_TRANSPORTER: inhibition of MPP+ uptake (MPP+: 1 uM) in Xenopus laevis oocytes [AID678785, Type: other] | Solute carrier family 22 member 2 [gi:81882176] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 103240245 | | CID | 305 | | Outcome | Unspecified | | IC50 | 217 [uM] | | BioAssay | TP_TRANSPORTER: inhibition of MPP+ uptake (MPP+: 1 uM) in Xenopus laevis oocytes | | AID | 678785 | | BioAssay type | other | | Target | Solute carrier family 22 member 2 [gi:81882176] | | PubMed | | | Data Table |  |
|
| 21 | [SID103240245] | Unspecified | Km | 240 | TP_TRANSPORTER: uptake (electrogenesis,-50mV) in Xenopus laevis oocytes [AID679825, Type: other] | Solute carrier family 22 member 1 [gi:81872095] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 103240245 | | CID | 305 | | Outcome | Unspecified | | Km | 240 [uM] | | BioAssay | TP_TRANSPORTER: uptake (electrogenesis,-50mV) in Xenopus laevis oocytes | | AID | 679825 | | BioAssay type | other | | Target | Solute carrier family 22 member 1 [gi:81872095] | | PubMed | | | Data Table |  |
|
| 22 | [SID103240245] | Unspecified | Km | 290 | Apparent Michaelis-Menten Constant (KM) for the acetylation of compound was calculated from Linewear-Burke plots by incubating for 10 minutes at 37 degrees Centigrade [AID52113, Type: Literature] | |   View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 103240245 | | CID | 305 | | Outcome | Unspecified | | Km | 290 [uM] | | BioAssay | Apparent Michaelis-Menten Constant (KM) for the acetylation of compound was calculated from Linewear-Burke plots by incubating for 10 minutes at 37 degrees Centigrade | | AID | 52113 | | BioAssay type | Literature | | Target | | | PubMed | 6737417 | | Data Table |  |
|
| 23 | [SID103240245] | Unspecified | Km | 346 | TP_TRANSPORTER: uptake in Xenopus laevis oocytes [AID679188, Type: other] | Solute carrier family 22 member 1 [gi:81872095] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 103240245 | | CID | 305 | | Outcome | Unspecified | | Km | 346 [uM] | | BioAssay | TP_TRANSPORTER: uptake in Xenopus laevis oocytes | | AID | 679188 | | BioAssay type | other | | Target | Solute carrier family 22 member 1 [gi:81872095] | | PubMed | | | Data Table |  |
|
| 24 | [SID103240245] | Unspecified | Km | 370 | TP_TRANSPORTER: uptake in Xenopus laevis oocytes [AID678993, Type: other] | Solute carrier family 22 member 1 [gi:81872095] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 103240245 | | CID | 305 | | Outcome | Unspecified | | Km | 370 [uM] | | BioAssay | TP_TRANSPORTER: uptake in Xenopus laevis oocytes | | AID | 678993 | | BioAssay type | other | | Target | Solute carrier family 22 member 1 [gi:81872095] | | PubMed | | | Data Table |  |
|
| 25 | [SID103240245] | Unspecified | IC50 | 398 | TP_TRANSPORTER: inhibition of TEA uptake (TEA: 100 uM) in Xenopus laevis oocytes [AID679826, Type: other] | Solute carrier family 22 member 1 [gi:81872095] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 103240245 | | CID | 305 | | Outcome | Unspecified | | IC50 | 398 [uM] | | BioAssay | TP_TRANSPORTER: inhibition of TEA uptake (TEA: 100 uM) in Xenopus laevis oocytes | | AID | 679826 | | BioAssay type | other | | Target | Solute carrier family 22 member 1 [gi:81872095] | | PubMed | | | Data Table |  |
|
| 26 | [SID103240245] | Unspecified | Km | 441 | TP_TRANSPORTER: uptake in Xenopus laevis oocytes [AID681624, Type: other] | Solute carrier family 22 member 2 [gi:81872789] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 103240245 | | CID | 305 | | Outcome | Unspecified | | Km | 441 [uM] | | BioAssay | TP_TRANSPORTER: uptake in Xenopus laevis oocytes | | AID | 681624 | | BioAssay type | other | | Target | Solute carrier family 22 member 2 [gi:81872789] | | PubMed | | | Data Table |  |
|
| 27 | [SID103240245] | Unspecified | Km | 604 | TP_TRANSPORTER: uptake in Xenopus laevis oocytes [AID681589, Type: other] | Solute carrier family 22 member 2 [gi:81872789] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 103240245 | | CID | 305 | | Outcome | Unspecified | | Km | 604 [uM] | | BioAssay | TP_TRANSPORTER: uptake in Xenopus laevis oocytes | | AID | 681589 | | BioAssay type | other | | Target | Solute carrier family 22 member 2 [gi:81872789] | | PubMed | | | Data Table |  |
|
| 28 | [SID103240245] | Unspecified | Km | 1100 | TP_TRANSPORTER: uptake in Xenopus laevis oocytes [AID679314, Type: other] | Solute carrier family 22 member 1 [gi:81872095] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 103240245 | | CID | 305 | | Outcome | Unspecified | | Km | 1100 [uM] | | BioAssay | TP_TRANSPORTER: uptake in Xenopus laevis oocytes | | AID | 679314 | | BioAssay type | other | | Target | Solute carrier family 22 member 1 [gi:81872095] | | PubMed | | | Data Table |  |
|
| 29 | [SID103240245] | Unspecified | IC50 | 1450 | TP_TRANSPORTER: inhibition of TEA uptake (TEA: 50 uM) in OCT2-expressing MDCK cells [AID681345, Type: other] | Solute carrier family 22 member 2 [gi:81872789] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 103240245 | | CID | 305 | | Outcome | Unspecified | | IC50 | 1450 [uM] | | BioAssay | TP_TRANSPORTER: inhibition of TEA uptake (TEA: 50 uM) in OCT2-expressing MDCK cells | | AID | 681345 | | BioAssay type | other | | Target | Solute carrier family 22 member 2 [gi:81872789] | | PubMed | | | Data Table |  |
|
| 30 | [SID103240245] | Unspecified | IC50 | 1452 | TP_TRANSPORTER: inhibition of TEA uptake (TEA: 50 uM) in OCT1-expressing MDCK cells [AID681348, Type: other] | Solute carrier family 22 member 1 [gi:81872095] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 103240245 | | CID | 305 | | Outcome | Unspecified | | IC50 | 1452 [uM] | | BioAssay | TP_TRANSPORTER: inhibition of TEA uptake (TEA: 50 uM) in OCT1-expressing MDCK cells | | AID | 681348 | | BioAssay type | other | | Target | Solute carrier family 22 member 1 [gi:81872095] | | PubMed | | | Data Table |  |
|
| 31 | [SID103240245] | Unspecified | Km | 2000 | TP_TRANSPORTER: uptake (electrogenesis) in Xenopus laevis oocytes [AID679635, Type: other] | Solute carrier family 22 member 2 [gi:81872789] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 103240245 | | CID | 305 | | Outcome | Unspecified | | Km | 2000 [uM] | | BioAssay | TP_TRANSPORTER: uptake (electrogenesis) in Xenopus laevis oocytes | | AID | 679635 | | BioAssay type | other | | Target | Solute carrier family 22 member 2 [gi:81872789] | | PubMed | | | Data Table |  |
|
| 32 | [SID103240245] | Unspecified | IC50 | 3013.01 | Inhibition acetylcholinesterase (AChE) enzyme. [AID32720, Type: Literature] | |   View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 103240245 | | CID | 305 | | Outcome | Unspecified | | IC50 | 3013.01 [uM] | | BioAssay | Inhibition acetylcholinesterase (AChE) enzyme. | | AID | 32720 | | BioAssay type | Literature | | Target | | | PubMed | 9435905 | | Data Table |  |
|
| 33 | [SID103240245] | Unspecified | | | Rate of acetylation of 13.0+/-1.1 umol compound by 1 g of choline acetyltransferase (ChAc) by incubating for 10 minutes at 37 degrees Centigrade [AID51964, Type: Literature] | |   View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 103240245 | | CID | 305 | | Outcome | Unspecified | | BioAssay | Rate of acetylation of 13.0+/-1.1 umol compound by 1 g of choline acetyltransferase (ChAc) by incubating for 10 minutes at 37 degrees Centigrade | | AID | 51964 | | BioAssay type | Literature | | Target | | | PubMed | 6737417 | | Data Table |  |
|
| 34 | [SID103240245] | Unspecified | | | Apparent Michaelis-Menten Constant (Vmax) for the acetylation of compound [AID52115, Type: Literature] | |   View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 103240245 | | CID | 305 | | Outcome | Unspecified | | BioAssay | Apparent Michaelis-Menten Constant (Vmax) for the acetylation of compound | | AID | 52115 | | BioAssay type | Literature | | Target | | | PubMed | 6737417 | | Data Table |  |
|
| 35 | [SID103240245] | Unspecified | | | Minimum concentration required to inhibit Pseudomonas aeruginosa ATCC 27853 [AID163955, Type: Literature] | |   View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 103240245 | | CID | 305 | | Outcome | Unspecified | | BioAssay | Minimum concentration required to inhibit Pseudomonas aeruginosa ATCC 27853 | | AID | 163955 | | BioAssay type | Literature | | Target | | | PubMed | 12954069 | | Data Table |  |
|
| 36 | [SID103240245] | Unspecified | | | Minimum concentration required to inhibit Pseudomonas aeruginosa ATCC 27853 [AID163958, Type: Literature] | |   View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 103240245 | | CID | 305 | | Outcome | Unspecified | | BioAssay | Minimum concentration required to inhibit Pseudomonas aeruginosa ATCC 27853 | | AID | 163958 | | BioAssay type | Literature | | Target | | | PubMed | 12954069 | | Data Table |  |
|
| 37 | [SID103240245] | Unspecified | | | Minimum concentration required to inhibit Staphylococcus aureus ATCC 25923 [AID207553, Type: Literature] | |   View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 103240245 | | CID | 305 | | Outcome | Unspecified | | BioAssay | Minimum concentration required to inhibit Staphylococcus aureus ATCC 25923 | | AID | 207553 | | BioAssay type | Literature | | Target | | | PubMed | 12954069 | | Data Table |  |
|
| 38 | [SID103240245] | Unspecified | | | Minimum concentration required to inhibit Staphylococcus aureus ATCC 25923 [AID207555, Type: Literature] | |   View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 103240245 | | CID | 305 | | Outcome | Unspecified | | BioAssay | Minimum concentration required to inhibit Staphylococcus aureus ATCC 25923 | | AID | 207555 | | BioAssay type | Literature | | Target | | | PubMed | 12954069 | | Data Table |  |
|
| 39 | [SID103240245] | Unspecified | | | Minimum concentration required to inhibit Enterococcus faecalis ATCC 29212 [AID68051, Type: Literature] | |   View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 103240245 | | CID | 305 | | Outcome | Unspecified | | BioAssay | Minimum concentration required to inhibit Enterococcus faecalis ATCC 29212 | | AID | 68051 | | BioAssay type | Literature | | Target | | | PubMed | 12954069 | | Data Table |  |
|
| 40 | [SID103240245] | Unspecified | | | Minimum concentration required to inhibit Enterococcus faecalis ATCC 29212 [AID68053, Type: Literature] | |   View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 103240245 | | CID | 305 | | Outcome | Unspecified | | BioAssay | Minimum concentration required to inhibit Enterococcus faecalis ATCC 29212 | | AID | 68053 | | BioAssay type | Literature | | Target | | | PubMed | 12954069 | | Data Table |  |
|
| 41 | [SID103240245] | Unspecified | | | Minimum concentration required to inhibit Escherichia coli ATCC 25922 [AID70621, Type: Literature] | |   View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 103240245 | | CID | 305 | | Outcome | Unspecified | | BioAssay | Minimum concentration required to inhibit Escherichia coli ATCC 25922 | | AID | 70621 | | BioAssay type | Literature | | Target | | | PubMed | 12954069 | | Data Table |  |
|
| 42 | [SID103240245] | Unspecified | | | Minimum concentration required to inhibit Escherichia coli ATCC 25922 [AID70623, Type: Literature] | |   View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 103240245 | | CID | 305 | | Outcome | Unspecified | | BioAssay | Minimum concentration required to inhibit Escherichia coli ATCC 25922 | | AID | 70623 | | BioAssay type | Literature | | Target | | | PubMed | 12954069 | | Data Table |  |
|
| 43 | [SID103240245] | Unspecified | | | Ratio between the binding affinities towards rat alpha2-beta4 and alpha2-beta2 nACh receptor using [3H]-EB as radioligand [AID231911, Type: Literature] | |   View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 103240245 | | CID | 305 | | Outcome | Unspecified | | BioAssay | Ratio between the binding affinities towards rat alpha2-beta4 and alpha2-beta2 nACh receptor using [3H]-EB as radioligand | | AID | 231911 | | BioAssay type | Literature | | Target | | | PubMed | 15050613 | | Data Table |  |
|
| 44 | [SID103240245] | Unspecified | | | Ratio between the binding affinities towards rat alpha3-beta4 and alpha3-beta2 nACh receptor using [3H]EB as radioligand [AID231912, Type: Literature] | |   View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 103240245 | | CID | 305 | | Outcome | Unspecified | | BioAssay | Ratio between the binding affinities towards rat alpha3-beta4 and alpha3-beta2 nACh receptor using [3H]EB as radioligand | | AID | 231912 | | BioAssay type | Literature | | Target | | | PubMed | 15050613 | | Data Table |  |
|
| 45 | [SID103240245] | Unspecified | | | Ratio between the binding affinities towards rat alpha3-beta4 and forebrain nACh receptor using [3H]EB as radioligand [AID231914, Type: Literature] | |   View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 103240245 | | CID | 305 | | Outcome | Unspecified | | BioAssay | Ratio between the binding affinities towards rat alpha3-beta4 and forebrain nACh receptor using [3H]EB as radioligand | | AID | 231914 | | BioAssay type | Literature | | Target | | | PubMed | 15050613 | | Data Table |  |
|
| 46 | [SID103240245] | Unspecified | | | Ratio between the binding affinities towards rat alpha4-beta4 and alpha4-beta2 nACh receptor using [3H]EB as radioligand [AID231915, Type: Literature] | |   View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 103240245 | | CID | 305 | | Outcome | Unspecified | | BioAssay | Ratio between the binding affinities towards rat alpha4-beta4 and alpha4-beta2 nACh receptor using [3H]EB as radioligand | | AID | 231915 | | BioAssay type | Literature | | Target | | | PubMed | 15050613 | | Data Table |  |
|
| 47 | [SID103240245] | Unspecified | | | Maximal response against Nicotinic acetylcholine receptor alpha 7 [AID242872, Type: Literature] | |   View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 103240245 | | CID | 305 | | Outcome | Unspecified | | BioAssay | Maximal response against Nicotinic acetylcholine receptor alpha 7 | | AID | 242872 | | BioAssay type | Literature | | Target | | | PubMed | 16033252 | | Data Table |  |
|
| 48 | [SID11110922] | Unspecified | | | Cytochrome panel assay with activity outcomes [AID1851, Type: other] | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 11110922 | | CID | 305 | | Outcome | Unspecified | | BioAssay | Cytochrome panel assay with activity outcomes | | AID | 1851 | | BioAssay type | other | | Target | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] | | PubMed | | | Data Table |  |
|
| 49 | [SID11110922] | Unspecified | | | Cytochrome panel assay with activity outcomes [AID1851, Type: other] | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 11110922 | | CID | 305 | | Outcome | Unspecified | | BioAssay | Cytochrome panel assay with activity outcomes | | AID | 1851 | | BioAssay type | other | | Target | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] | | PubMed | | | Data Table |  |
|
| 50 | [SID103240245] | Unspecified | | | TP_TRANSPORTER: uptake in OCT2-expressing HEK-293 cells [AID681628, Type: other] | Solute carrier family 22 member 2 [gi:81872789] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 103240245 | | CID | 305 | | Outcome | Unspecified | | BioAssay | TP_TRANSPORTER: uptake in OCT2-expressing HEK-293 cells | | AID | 681628 | | BioAssay type | other | | Target | Solute carrier family 22 member 2 [gi:81872789] | | PubMed | | | Data Table |  |
|